Understanding the window of opportunity concept in early rheumatoid arthritis
Open Access
- 2 July 2003
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (7), 1771-1774
- https://doi.org/10.1002/art.11156
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Five‐year followup of rheumatoid arthritis patients after early treatment with disease‐modifying antirheumatic drugs versus treatment according to the pyramid approach in the first yearArthritis & Rheumatism, 2003
- The benefits of early treatment in rheumatoid arthritis: Confounding by indication, and the issue of timingArthritis & Rheumatism, 2003
- Influence of disease‐modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception studyArthritis & Rheumatism, 2003
- Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomesArthritis & Rheumatism, 2002
- Delay to institution of therapy and induction of remission using single‐drug or combination–disease‐modifying antirheumatic drug therapy in early rheumatoid arthritisArthritis & Rheumatism, 2002
- COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief interventionArthritis & Rheumatism, 2002
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisThe New England Journal of Medicine, 2000
- Aggressive treatment in early rheumatoid arthritis: a randomised controlled trialAnnals Of The Rheumatic Diseases, 2000
- Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trialThe Lancet, 1999
- Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisThe Lancet, 1997